文献速递血栓与止血贫血与红细胞疾病

ITP患者社区获得性肺炎住院风险预测模型ACPA

A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.
PubMed 文献 · Blood Adv · 2020-01-01

本研究基于中国10个大型医疗中心非脾切除成人ITP患者数据,回顾性建立并验证了包含年龄、Charlson合并症指数评分、初始血小板计数和初始绝对淋巴细胞计数的4项ACPA模型,用于预测CAP住院风险。推导队列AUC为0.853(95%CI 0.818-0.889),验证队列AUC为0.862(95%CI 0.807-0.916),校准良好,决策曲线分析显示临床获益。

要点

  • ACPA模型含年龄、CCI评分、初始血小板计数、初始绝对淋巴细胞计数4项。
  • 推导队列AUC 0.853(95%CI 0.818-0.889),验证队列AUC 0.862(95%CI 0.807-0.916)。
  • 模型校准良好,决策曲线分析提示ITP患者可从临床应用中获益。

核心结论

  • ACPA模型可预测非脾切除成人ITP患者CAP住院的发生,有助于识别高风险患者。

研究设计与样本

  • 回顾性研究,来自中国10个大型医疗中心非脾切除成人ITP患者。
  • 推导队列含145例CAP住院和1360例无CAP住院患者,来自5个中心。
  • 验证队列含63例CAP住院和526例无CAP住院患者,来自另外5个中心。

主要发现

  • 推导队列ACPA模型AUC为0.853(95%CI 0.818-0.889)。
  • 验证队列ACPA模型AUC为0.862(95%CI 0.807-0.916)。
  • 校准图显示估计概率与观察概率高度一致。
  • 决策曲线分析提示ITP患者可从ACPA模型的临床应用中获益。

关键数值与推荐

  • ACPA模型包含4项:年龄、Charlson合并症指数评分、初始血小板计数、初始绝对淋巴细胞计数。

临床怎么用

  • 可用于识别ITP患者中CAP住院高风险者,辅助临床决策。

局限性

  • 本研究为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection is one of the primary causes of death from immune thrombocytopenia (ITP), and the lungs are the most common site of infection. We identified the factors associated with hospitalization for community-acquired pneumonia (CAP) in nonsplenectomized adults with ITP and established the [corrected] (ACPA) prediction model to predict the incidence of hospitalization for CAP. This was a retrospective study of nonsplenectomized adult patients with ITP from 10 large medical centers in China. The derivation cohort included 145 ITP inpatients with CAP and 1360 inpatients without CAP from 5 medical centers, and the validation cohort included the remaining 63 ITP inpatients with CAP and 526 inpatients without CAP from the other 5 centers. The 4-item ACPA model, which included age, Charlson Comorbidity Index score, initial platelet count, and initial absolute lymphocyte count, was established by multivariable analysis of the derivation cohort. Internal and external validation were conducted to assess the performance of the model. The ACPA model had an area under the curve of 0.853 (95% confidence interval [CI], 0.818-0.889) in the derivation cohort and 0.862 (95% CI, 0.807-0.916) in the validation cohort, which indicated the good discrimination power of the model. Calibration plots showed high agreement between the estimated and observed probabilities. Decision curve analysis indicated that ITP patients could benefit from the clinical application of the ACPA model. To summarize, the ACPA model was developed and validated to predict the occurrence of hospitalization for CAP, which might help identify ITP patients with a high risk of hospitalization for CAP.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Wu YJ, Hou M, Liu HX, et al. A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data. Blood Adv. 2020. PMID: 33232474. doi:10.1182/bloodadvances.2020003074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。